Laurion Capital Management LP - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.

Quarter-by-quarter ownership
Laurion Capital Management LP ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$2,131,060
-37.4%
83,9000.0%0.02%
-6.2%
Q4 2022$3,402,984
+22.5%
83,900
-0.2%
0.02%0.0%
Q3 2022$2,779,000
-7.3%
84,095
-1.2%
0.02%
-65.2%
Q2 2022$2,997,000
+68.8%
85,128
+204.1%
0.05%
+228.6%
Q4 2019$1,776,000
+145.6%
27,998
-72.1%
0.01%
+133.3%
Q1 2018$723,000100,2810.01%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q2 2022
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders